Before joining Qiming, Dr. Hu was VP and Head of (External) Innovation Center China at Bayer Healthcare, responsible for building and managing partnerships for Global Drug Discovery with organizations in Greater China. Prior to that, she was Director of Licensing & External Research at Merck&Co covering Greater China for Worldwide Licensing & External Research.
She worked previously at Roche Palo Alto as Head of Functional Biology, at Affymetrix as Program Manager of Pharmacogenomics, and at Human Genome Sciences as Scientist of Protein Therapeutics.
Dr. Hu obtained her post-doctoral training at Harvard Medical School, PhD from Univ. of Texas Graduate School of Biomedical Sciences at MD Anderson Cancer Center, and BS degree in Biochemistry from Peking Univ. She is a board member of BayHelix and Chinese-American BioPharma Society (CABS).